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AbstrAct 
Introduction: Class III and IV are the most ominous
among the classes of lupus nephritis (LN)  and there are
contradictory reports on whether LN class IV-G (glo bal)
differs from LN class IV-S (segmental), as envisaged by
the International Society of Nephrology and the Renal
Pathology Society (ISN/RPS) 2003 classification. These
subcategories are not validated for LN class III. This study
was designed to assess the differences between global
and segmental subclasses in classes III and IV of LN.
Patients and Methods: In a retrospective analysis, the
kidney biopsies of 84 patients with new-onset LN were
analyzed. The Student’s t-test and Mann-Whitney test
were employed to compare differences between the
means of continuous variables among the two groups.
Fisher’s exact test was used to compare the categorical
variables. A p-value <0.05 was considered statitistical-
ly significant.
Results: Of 84 patients, 69 (82.1%) were females and
15 (17.9%) males, with the female to male ratio of
4.6:1. The mean age of all patients was 32.7±12.6 years.
The mean serum creatinine at the time of biopsy was
1.5±0.94 mg/dl (range: 0.7 to 5 mg/dl) and the mean
urinary protein excretion was 1.6±1.9 g/day. Among 84
biopsies, 26(30.95%) were classified as class III and 37
(44.05%) to class IV LN. In class IV LN, serum creati-
nine was significantly higher in global versus segmen-
tal subcategory (2.4±1 vs. 1.1±0.5 mg/dl; p=0.034),
while 24-h proteinuria was not significantly different
between the subcategories (2.7±1.2 vs. 3.1±1.0 g/d,
p=0.56). In LN class III, the mean age, serum creatinine
and 24-hour proteinuria did not show significant diffe -
Nasri H1, Baradaran A2, Rafieian-kopaei M3, Mubarak M4
rences between the global and segmental subcategories
(37±17 vs. 30±15 years, p=0.58; 1.2±0.2 vs. 1.25±0.6
mg/dl, p=0.66; 2.03±0.5 vs. 3.1±3.5 g/day, p=0.45, res -
pectively). The proportion of glomeruli showing en-
docapillary proliferation was significantly higher in glo -
bal than in segmental subclasses (94.25% vs. 5.72;
p=0.026) in class IV LN. The activity and chronicity
percent also revealed higher values in global subclass vs.
segmental subclass of class IV LN (p=0.038 and
p=0.045, respectively). These parameters were not si -
gnificantly different among the global and segmental
subcategories of class III LN (p>0.5 for all parameters).
Conclusion: In conclusion, our study showed signifi-
cant differences in renal function and some pathologi-
cal features on renal biopsies among the global and se -
gmental subclasses of class IV LN. There were no
signifi cant differences among these subclasses of class
III LN. Further, and larger studies are needed on this
subject to substantiate the above results.
Keywords: Focal and global lupus nephritis; Lupus
pathology; ISN/RPS classification.
IntroductIon
The International Society of Nephrology and Renal
Pathology Society (ISN/RPS), proposed a new classifi-
cation for lupus nephritis (LN) in 20031. The proposed
changes sought to improve inter-observer agreement
and reproducibility and to eliminate the ambiguities
seen with prior classifications2-5. The most significant
change in the new classification is undoubtedly the
subdi vision of class IV LN1. Diffuse endocapillary or
extracapillary glomerulonephritis involving 50% of all
glomeruli or more (described as class IV) is divided into
two subcategories: global and segmental1, 6-11. Diffuse
global LN (class IV-G) is identified when the lesions in-
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volve more than 50% of the glomerular tuft, whereas,
diffuse segmental LN (IV-S) is defined when at least
50% of the involved glomeruli exhibit lesions in -
volving less than half of the glomerular tuft1, 2, 10. Addi -
tionally, both subcategories are scored also for active
and chronic lesions. In fact, after the presentation of
the ISN/RPS classification, comparisons between LN
subclasses IV-S and IV-G became a matter of dis-
pute1,2,10. While the two subclasses revealed distinct
clinical and morphologic characteristics at baseline,
some studies showed that the outcome did not vary
significantly. Additionally, on repeat biopsies, transi-
tions from IV-G to IV-S or converse were detected. This
finding may indicate a similar pathogenesis for these
two forms. Various subsequent investigators tried to
show better outcome or better res ponse to cyclophos-
phamide induction therapy in LN class IV-S than in
IV-G11-17. However, the recently reported studies were
conducted in relatively small groups of patients who
did not consistently receive similar therapies10,12,17. Gi -
ven that, there are few stu dies currently available con-
cerning the association of demographic, clinical, and
morphologic lesions of segmen tal and global sub-
classes of classes III and IV LN, and whilst the conclu-
sions of various investigations are contradictory, our
current study sought to ana lyze the existing evidence
on the differences between these subcategories in clas -
ses III and IV of LN.
pAtIents And methods
study And settIng
The present study is a retrospective analysis of kidney
biopsies of 84 patients with new-onset LN, who were
referred by either rheumatologists or nephrologists.
The patients fulfilled the revised American College of
Rheumatology (ACR) criteria for systemic lupus
nephritis (SLE)18 as defined by their physicians. Only
those patients were included in whom no pre-biopsy
treatment was given. Kidney biopsies were reported
according to the 2003 ISN/RPS classification for LN1.
The study was performed from January 2008 to Ja -
nuary 2014. All performed kidney biopsies were re-
ferred to a single nephropathology laboratory. The
kidn ey morphologic lesions were reviewed by a single
nephropathologist.
chArActerIzAtIon of ln
The definitive diagnosis of LN was based on clinical
and laboratory data and finally by immunofluorescence
(IF) study which included significant positive C1q
(more than 2+ intensity) accompanied by IgG, IgA, IgM
and C3 deposits (full-house pattern), which were semi-
quantitatively graded from zero to 3+ according to the
intensity of fluorescence19,20. Morphologic lesions were
assessed as specified by the ISN/RPS 2003 LN classifi-
cation by light microscopy (LM)1,7,12.
defInItIon of morphologIc vArIAbles
The morphological assessment of the LM was recor ded
according to the ISN/RPS 2003 histological definition
of classes of LN1, 7, 12. Renal biopsies containing <10
glomeruli were excluded. Class III (focal LN) was cha -
racterized as focal glomerulonephritis involving less
than 50% of all glomeruli, whereas, class IV LN as diffu -
se glomerulonephritis involving ≥50% of total number
of glomeruli, either with global (class IV-G) or segmen -
tal (class IV-S) involvement, and also with percent of ac-
tive or chronic lesions1,7,12. Diffuse segmental prolife -
rative LN (IV-S) was designated when at least 50% of
the involved glomeruli showed lesions involving less
than half of the glomerular tuft. Diffuse global LN (IV-
-G) was diagnosed when the lesions affected more than
50% of the glomerular tuft1,7,12. The activity and
chronicity was assessed as the proportion (percentage)
of glomeruli showing active lesions, rather than the Na-
tional Institutes of Health (NIH) activity and chronici -
ty indices. 
demogrAphIcs And lAborAtory dAtA 
We obtained the patients’ demographic and laborato-
ry data at the time of their biopsies, as well as the patho-
logical variables on renal biopsies, from a review of
their original renal biopsy request forms.
ethIcAl Issues
(1) The research followed the tenets of the Declaration
of Helsinki; (2) informed consent was obtained; (3) the
research was approved by the institutional review board.
stAtIstIcAl AnAlysIs
All continuous values are expressed as mean ± stan-
dard deviation (SD) and categorical variables as num-
bers and percentages. Normality assumption was
checked for continuous variables and student’s t-test
and Mann-Whitney tests were employed as appropri-
ate to compare the differences between the means of
continuous variables among the groups. Fisher’s exact
test  was used to compare the categorical variables
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among the groups. Data were analyzed by Stata soft-
ware (Stata Corp. 2011. Stata Statistical Software: Re-
lease 12. College Station, TX: Stata Corp LP). A p-va -
lues of less than 0.05 was assumed to be significant.
results
In our observational study, we enrolled a total of 84
LN patients’ biopsies. All patients were of Iranian ori-
gin and racially homogeneous. Of 84 patients, 69
(82.1%) were females and 15 (17.9%) males, with a fe-
male to male ratio of 4.6:1. The mean age of all pa-
tients was 32.7±12.6 years. The mean serum creati-
nine at the time of biopsy was 1.5±0.94 mg/dl and the
mean 24-hour proteinuria was 1.6±1.9 g. 
Among 84 patients, 63 (75%) belonged to the proli -
ferative LN classes III (26; 30.95%) and IV (37;
44.05%). Table I illustrates the frequency distribution
of LN classes III and IV and their subclassification
accor ding to the global and segmental subcategories.
These two classes of LN formed the basis for further
statistical analysis regarding the differences between
global and segmental subcategories of glomerular in-
volvement in LN. Tables II and III illustrate the
differen ces in demographic, laboratory, and pathologi -
cal parameters at the time of renal biopsies among the
global and segmental subclasses of class III and IV LN
cases. 
The vast majority of cases of LN class III showed
segmental glomerular involvement (20/26; 76.9%),
while in LN class IV, global involvement was much
more common (34/37; 91.9%). 
In class III LN, there was no significant difference in
the mean age, mean serum creatinine, the amount of
proteinuria or the pathological features on renal bio -
psy among the global and segmental subcategories (all
parameters; p >0.5), as shown in Table II. 
In class IV LN, there was a significant difference in
the mean serum creatinine between global and seg-
mental subcategories (2.4±1 vs. 1.1 ± 0.5 mg/dl;
p=0.034), while proteinuria showed no significant dif-
ference (p=0.56). The proportion of endocapillary pro-
liferation showed significant difference between glo -
bal and segmental subclasses (0.94 vs. 0.56; p= 0.026)
of class IV LN. Analysis of the activity and chronicity
percent revealed higher values of both activity
(p=0.038) and chronicity percent (p=0.045) in global
subclass vs. segmental subclass. 
However, there was no significant difference in mean
age, amount of proteinuria, proportion of totally scle-
rotic glomeruli and proportion of crescents between
the subclasses of global and segmental lesions (p>0.5).
An analysis of all patients of classes III and IV LN re-
tAble I. the frequency dIstrIbutIon of lupus nephrItIs Into clAsses III And Iv And globAl And
segmentAl subcAtegorIes
Total patients Global Segmental
Classification Number Percent Number Percent Number Percent
Class III 26 30.95 6 23.07 20 76.92
Class IV 37 44.04 34 91.89 3 8.1
Total 63 75 40 63.5 23 36.5
tAble II. A compArIson of the pAtIents’ dAtA In clAss III lupus nephrItIs AccordIng to the 
globAl And segmentAl subcAtegorIes At the tIme of renAl bIopsy                                       
Parameters Total n=26 Global n=6 Segmental n=20 p. Value
Age, mean±SD (years) 30.7 ± 15.25 34 ± 17 30 ± 15 0.589
Creatinine, mean±SD (mg/dl) 1.2 ± 0.56 1.2 ± 0.2 1.25 ± 0.6 0.669
Proteinuria/day, mean±SD (g) 2.8 ±  2.9 2.032 ± 0.5 3.1 ± 3.5 0.455
Activity, mean±SD (%) 30 ± 23.34 36.3 ± 29 27.6 ± 20 0.418
Chronicity, mean±SD (%) 8.3 ± 10.05 10 ± 12 8.6 ± 9.7 0.775
Proportion of endocapillary proliferation, n (%) 20 (76.9) 5 (25) 15 (75) 0.671
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vealed higher values of serum creatinine (1.98±1.1 vs.
1.3 ± 0.69 mg/dl; p=0.01) in global subclass than seg-
mental subcategory. The proteinuria was not signifi-
cantly different between the two subcategories
(2.6±1.2 vs. 3.1 ± 3.1 g/day; p=0.35). There was a signi -
ficant difference of active lesions (61.92 ± 30.36 vs.
26.82 ± 19.94%; p<0.001) with higher values ob-
served in the global subclass, while there was no sig-
nificant difference of chronic lesions between the two
subclasses (p=0.60). In this study, we also detected a
higher value of endocapillary proliferation (p=0.04)
and extracapillary proliferation (p=0.03) in global sub-
class in comparison to segmental subclass. Table IV
summarizes the comparisons between the global and
segmental subcategories of all patients of classes III
and IV LN.
Figure 1 shows some representative lesions of clas -
ses III and IV segmental and global lesions.
dIscussIon
The ISN/RPS 2003 classification of LN is getting
widespread acceptance and seems to be achieving its
goals of reproducibility and clinical relevance1,7,12. A
number of innovations were sought in the formulation
of this classification. In particular, class IV LN was
subc lassified into segmental or global subclasses accor -
ding to the proportion of the capillary tuft involve-
ment. The distinction between IV-S and IV-G may have
significant implications for differences in the patho-
genesis and outcome1,7,12. There is still controversy as
to whether kidney outcomes differ between the glo bal
and segmental subclasses of class IV LN (diffuse pro-
liferative LN)7,12. Indeed, various retrospective investi-
gations have revealed significant clinical and morpho-
logical differences between IV-G and IV-S, however, no
significant differences in the outcome have been de-
tected yet7,12. 
In this study, no significant differences of the ana-
lyzed parameters were found among the global and
segmental subclasses of LN class III. This is not sur-
prising given the lack of validation of this subdivision
in LN class III. Thus, our results add further evidence
to this observation. However, as shown in Table I, there
were very few cases of global glomerular involvement
in LN class III. This marked skewness of the cases in
favor of segmental involvement in LN class III may
partly be responsible for the lack of statistical signifi-
cance of the results. 
Among the class IV LN subcategories, serum crea-
tinine, proportion of endocapillary proliferation and
tAble III. A compArIson of the pAtIents’ dAtA In clAss Iv lupus nephrItIs AccordIng to the globAl And
segmentAl subcAtegorIes At the tIme of renAl bIopsy
Parameters Total n=37 Global n=34 Segmental n=3 p. Value
Age,  mean±SD (years) 32.8 ± 12.2 33.2 ± 12 27.6 ± 2 0.431
Creatinine, mean±SD  (mg/dl) 2.1 ± 1.09 2.4 ± 1 1.1 ± 0.5 0.034
Proteinuria/day, mean±SD  (g) 2.7 ± 1.2 2.7 ± 1.2 3.1 ± 1.04 0.563
Activity, mean±SD  (%) 64.16 ± 28.62 68.4 ± 26 35 ± 21.7 0.038
Chronicity, mean±SD  (%) 17.9 ± 21.37 16.2 ± 10 30.6 ± 25 0.045
Proportion of endocapillary proliferation, n (%) 35 (94.6) 33 (94.28) 2 (5.72) 0.026
tAble Iv. the mAIn chArActerIstIcs of pAtIents AccordIng to the globAl And segmentAl subclAsses
of clAss III And Iv lupus nephrItIs At the tIme of bIopsy.
Parameters Total n=63 Global n=40 Segmental n=23 p. Value
Age, mean ± SD  (years) 31.98 ± 13.47 33.25 ± 13.23 29.95 ± 13.83 0.35
Creatinine, mean ± SD  (mg/dl) 1.7 ± 1.01 1.98 ± 1.1 1.3 ± 0.69 0.01
Proteinuria/day, mean ± SD  (g) 2.7 ± 2.1 2.6.9 ± 1.2 3.1 ± 3.1 0.35
Activity, mean ± SD (%) 50 ± 31 61.92 ± 30.36 26.82 ± 19.94 <0.001
Chronicity, mean ± SD  (%) 13.95 ± 18.13 14.87 ± 19.21 12.35 ± 16.36 0.60
Proportion of endocapillary proliferation, n (%) 55 (87.3) 37 (68.51) 17 (31.48) 0.042
ÓRgÃO OfICIAL dA SOCIEdAdE PORTUgUESA dE REUMATOLOgIA
142
CliNiCopatHologiCal CorrelatioNs of lupus NepHritis
the activity and chronicity percent were significantly
higher in the global subcategory. Other parameters did
not show significant differences among the two sub-
categories. One possible reason for this may also be the
very few cases of segmental involvement in class IV LN.
Because of the markedly skewed distribution of the
global and segmental cases in LN classes III and IV, we
also analyzed all the parameters among all the glo bal
and segmental subcategories of combined classes III
and IV LN. On doing this, we observed significant dif-
ferences in the serum creatinine, activity percent and
proportion of endocapillary proliferation. The 
other parameters did not show significant differences,
as shown in Table IV.   
To assess the differences between LN class IV-G and
IV-S in Koreans and focus on the response to cy-
clophosphamide induction treatment, Kim et al., stu -
died 52 patients with biopsy-proven diffuse LN, who
had been treated with intravenous (I/V) cyclophos-
phamide over a 10-year period22. Of the 42 patients
evaluated, 71% had IV-G and 29% had IV-S. They
found that pre-treatment 24-hour urinary protein was
significantly higher in IV-G than in IV-S individuals.
Following induction therapy, complete remission rates
were significantly higher in individuals with IV-S than
in patients with IV-G of LN. They concluded that, class
IV-G of LN responded more poorly to induction thera -
py with I/V cyclophosphamide pulse than class IV-S of
LN22. In contrast to the above study, 24-hour protei nuria
was not significantly different among IV-G and IV-S in
our study. This may be partly due to the fact that the
number of IV-S cases was very low (8.1%) in our study.
Moreover, we also did not analyze the treatment or the
response to therapeutic intervention in the present
study. 
To evaluate whether the different ISN/RPS classes of
LN have a distinct baseline presentation, short-term res -
ponse to immunosuppression and long-term progno sis,
Vandepapelière et al., studied 98 patients with new-on-
set LN23. At baseline, serum creatinine and 24-hour
proteinuria were higher in class IV-G, and the acti vity
index on kidney biopsy in class IV-S and IV-G com-
pared to class III. They found that poor outcomes did
not differ significantly between the groups, although
there was a trend toward more kidney impairment at
follow-up in class IV-G compared to classes IV-S and III.
They interpreted that subclassifying proliferative LN
into classes III, IV-S and IV-G offers less clinically dis-
criminant prognostic information than baseline
chronicity index23. This may be due to the availability
and the use of very potent drugs for proliferative LN,
which control the active lesions rather than the chro -
nic lesions. To assess the differences between IV-G and
IV-S of LN in a Chinese population with LN, a total of
172 cases of SLE were classified as class IV LN, in-
cluding 152 cases with IV-G and 20 cases with IV-S.
Lower serum creatinine in IV-S was detected24. The re-
sults from our study support this finding. On patho-
logical evaluation, the score of endocapillary hypercel-
lularity, and total activity indices were significantly low-
er in IV-S. We also found similar results for these pa-
rameters. Yu et al., concluded that there are significant
differences in the clinical and pathological manifesta-
tions between IV-S and IV-G LN which need further in-
vestigation24. 
To evaluate the use of the ISN/RPS LN classification
and the role of repeated renal biopsy in routine clini-
cal practice, 142 patients with LN were investigated by
Pagni et al.25. Their study showed that the serum crea-
tinine, proteinuria, blood pressure levels and histologi -
cal classes were more severe in class IV-G, both at first
and repeated renal biopsy25. They concluded that, mor-
fIgure 1. Morphological appearances of different classes of
lupus nephritis. Each of these lesions may be seen in lupus
class III and IV nephritis, but segmental lesions are common in
class III and global in class IV. A) Medium-power view of a
glomerulus showing segmental necrotizing lesion with focal
crescent formation. Classified as a segmental and active lesion
(Silver stain, ×200). B) Another glomerulus from the same
biopsy showing segmental sclerosing lesion. Classified as a
chronic lesion. (Silver stain, ×200). C) A glomerulus showing
global or diffuse proliferative lesion of the mesangiocapillary
type. A tiny crescent is seen at 10’0 clock position.
(Hematoxlin and eosin stain, ×200). D) Another glomerulus
showing diffuse or global proliferation and crescent formation.
(Periodic acid-Schiff stain, ×200)
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phological differences between segmental and global
forms do exist, perhaps due to different pathogenetic
mechanisms25. Similarly, Gao et al., detected that class
IV-G had more severe hypertension and higher scores
of interstitial fibrosis, glomerular active lesions, tubu-
lar and vascular lesions. Class IV-S had a higher per-
centage of glomerular fibrinoid necrosis. Class IV-S
appea red to have a higher rate of transformation to
class II than class IV-G26. To evaluate the association of
active and chronic lesions with kidney outcome ac-
cording to the ISN/RPS classification in patients with
LN, Kojo et al., conducted an investigation on 99 biop-
sy-proven subjects with LN. They observed a worse
renal outcome of IV-G group compared with the IV-S
group; however, the difference was not statistically sig-
nificant27, 28. Unfortunately, we were not able to ana-
lyze the renal outcome in our current study. 
lImItAtIons In the study
There are a number of limitations to the current study.
The study is retrospective in nature and originates from
a single center. The biopsies were evaluated by a sin-
gle nephropathologist, which, although ensured con-
sistency of the findings, remains a weakness of the
study. There is also no information on the treatment
and most importantly, on the outcome of the cohort.
We are actively following this cohort and will share
our experience on these aspects in near future28. The
numbers of global and segmental cases are also
markedly skewed in classes III and IV LN and this may
account for the non-significant results in the current
study. A large study with more cases of both subcate-
gories in both classes of LN is needed to clarify these
results. 
conclusIon
In conclusion, the results from our study showed signi -
ficant differences in renal function and some patholo -
gical features on renal biopsies among the global and
segmental subclasses of class IV LN. There were no
signi ficant differences among these subclasses of class
III LN.  Further, and larger studies are needed on this
subject to substantiate the above results.
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